PT841924E - Compostos de benzimidazolo - Google Patents

Compostos de benzimidazolo

Info

Publication number: PT841924E
Authority: PT; Portugal
Prior art keywords: benzimidazole compounds; benzimidazole; compounds
Prior art date: 1995-08-02

Application number

PT96925875T

Other languages

English (en)

Inventor

Roger John Griffin

Alan Hilary Calvert

Nicola Jane Curtin

David Richard Newell

Bernard Thomas Golding

Original Assignee

Univ Newcastle Ventures Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-02

Filing date

1996-07-30

Publication date

2003-02-28

1995-08-02 Priority claimed from GBGB9515843.2A external-priority patent/GB9515843D0/en

1996-05-30 Priority claimed from GBGB9611245.3A external-priority patent/GB9611245D0/en

1996-07-30 Application filed by Univ Newcastle Ventures Ltd filed Critical Univ Newcastle Ventures Ltd

2003-02-28 Publication of PT841924E publication Critical patent/PT841924E/pt

Links

150000001556 benzimidazoles Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Data Exchanges In Wide-Area Networks (AREA)

PT96925875T 1995-08-02 1996-07-30 Compostos de benzimidazolo PT841924E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9515843.2A GB9515843D0 (en)	1995-08-02	1995-08-02	Benzimidazole compounds
GBGB9611245.3A GB9611245D0 (en)	1996-05-30	1996-05-30	Benzimidazole compounds

Publications (1)

Publication Number	Publication Date
PT841924E true PT841924E (pt)	2003-02-28

Family

ID=26307504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96925875T PT841924E (pt)	1995-08-02	1996-07-30	Compostos de benzimidazolo

Country Status (26)

Country	Link
US (2)	US6100283A (pt)
EP (1)	EP0841924B1 (pt)
JP (1)	JPH11510154A (pt)
KR (1)	KR100447539B1 (pt)
CN (1)	CN1159007C (pt)
AP (1)	AP866A (pt)
AT (1)	ATE225173T1 (pt)
AU (1)	AU714873B2 (pt)
BR (1)	BR9610051A (pt)
CA (1)	CA2225465A1 (pt)
CZ (1)	CZ30398A3 (pt)
DE (1)	DE69624115T2 (pt)
DK (1)	DK0841924T3 (pt)
EA (1)	EA000999B1 (pt)
ES (1)	ES2183004T3 (pt)
HU (1)	HUP9901092A3 (pt)
IL (1)	IL123147A (pt)
MX (1)	MX9800927A (pt)
NO (1)	NO317033B1 (pt)
NZ (1)	NZ313713A (pt)
OA (1)	OA10661A (pt)
PL (1)	PL324869A1 (pt)
PT (1)	PT841924E (pt)
SK (1)	SK13598A3 (pt)
TR (1)	TR199800127T1 (pt)
WO (1)	WO1997004771A1 (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2776291B1 (fr) *	1998-03-18	2000-06-16	Pf Medicament	Nouveaux derives bis-benzamides, leur procede de fabrication, les compositions pharmaceutiques les contenant et leur utilisation comme medicament
US6911462B2 (en) *	1998-05-22	2005-06-28	Avanir Pharmaceuticals	Benzimidazole compounds for regulating IgE
US6919366B2 (en) *	1998-05-22	2005-07-19	Avanir Pharmaceuticals	Benzimidazole derivatives as modulators of IgE
UA65635C2 (uk) *	1998-09-03	2004-04-15	Н-Гене Кутато Кфт.	НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ
PL347500A1 (en)	1998-11-03	2002-04-08	Basf Ag	Substituted 2-phenylbenzimidazoles, the production thereof and their use
ID28846A (id) *	1998-11-17	2001-07-05	Basf Ag	2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ATE259789T1 (de)	1998-11-27	2004-03-15	Abbott Gmbh & Co Kg	Substituierte benzimidazole und ihre verwendung als parp inhibitoren
DE19916460B4 (de) *	1999-04-12	2006-12-21	Abbott Gmbh & Co. Kg	Substituierte Benzimidazole, deren Herstellung und Anwendung
MXPA01007001A (es)	1999-01-11	2002-07-30	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas.
FR2788518B1 (fr) *	1999-01-14	2001-03-02	Centre Nat Rech Scient	Nouveaux carbamates actives stables, leur procede de preparation et leur utilisation pour la preparation d'urees
DE19918211A1 (de) *	1999-04-22	2000-10-26	Basf Ag	Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
DE19920936A1 (de) *	1999-05-07	2000-11-09	Basf Ag	Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
ECSP003637A (es) *	1999-08-31	2002-03-25	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas
AU7314200A (en) *	1999-09-17	2001-04-24	Yamanouchi Pharmaceutical Co., Ltd.	Benzimidazole derivatives
DE19946289A1 (de) *	1999-09-28	2001-03-29	Basf Ag	Benzodiazepin-Derivate, deren Herstellung und Anwendung
US6759425B2 (en)	1999-10-21	2004-07-06	Avanir Pharmaceuticals	Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
IT1315267B1 (it) *	1999-12-23	2003-02-03	Novuspharma Spa	Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
ES2290115T3 (es) *	2000-02-01	2008-02-16	ABBOTT GMBH & CO. KG	Compuestos heterociclicos y su aplicacion como inhibidores de parp.
DE10021468A1 (de) *	2000-05-04	2001-11-08	Basf Ag	Verwendung von PARP-Inhibitoren in kosmetischen Zubereitungen
DE10022925A1 (de) *	2000-05-11	2001-11-15	Basf Ag	Substituierte Indole als PARP-Inhibitoren
DK1368028T3 (da) *	2001-03-12	2007-12-27	Avanir Pharmaceuticals	Benzimidazolforbindelser til IgE-modulering og inhibering af cellulær profi-ferering
US7072771B2 (en) *	2001-06-07	2006-07-04	University Of Kentucky Research Foundation	Selective PARP-1 targeting for designing chemo/radio sensitizing agents
AU2002334355A1 (en) *	2001-09-06	2003-03-18	Prochon Biotech Ltd.	Protein tyrosine kinase inhibitors
DE10201240A1 (de) *	2002-01-15	2003-07-24	Bayer Ag	Substituierte Alkyluracile und ihre Verwendung
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
US20040034078A1 (en) *	2002-06-14	2004-02-19	Agouron Pharmaceuticals, Inc.	Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
TWI276631B (en) *	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en)	2002-09-12	2004-03-25	Avanir Pharmaceuticals	Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
EP1590333A4 (en) *	2003-01-23	2008-04-30	Crystalgenomics Inc	GLYCOGENE SYNTHASE KINASE 3BETA INHIBITOR, COMPOSITION AND PROCESS FOR PREPARING THE SAME
EP1613313B1 (en) *	2003-04-17	2007-06-06	Janssen Pharmaceutica N.V.	2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
EP1651198A2 (en) *	2003-08-08	2006-05-03	Avanir Pharmaceuticals	Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
TWI375673B (en)	2005-04-11	2012-11-01	Abbott Lab	1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
WO2006110683A1 (en)	2005-04-11	2006-10-19	Abbott Laboratories	2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
ZA200800907B (en)	2005-07-18	2010-04-28	Bipar Sciences Inc	Treatment of cancer
JP5221368B2 (ja)	2005-11-14	2013-06-26	サントルナシオナルドゥラルシェルシェサイアンティフィク（セエヌエールエス）	Ｐａｒｐ活性のインヒビター及びその使用
CN101309908A (zh)	2005-11-15	2008-11-19	艾博特公司	作为有效parp抑制剂的取代的1h-苯并咪唑-4-甲酰胺化合物
US20080293795A1 (en) *	2006-01-17	2008-11-27	Abbott Laboratories	Combination therapy with parp inhibitors
US20080280867A1 (en) *	2006-01-17	2008-11-13	Abbott Laboratories	Combination therapy with parp inhibitors
US20090029966A1 (en) *	2006-01-17	2009-01-29	Abbott Laboratories	Combination therapy with parp inhibitors
US20080146638A1 (en) *	2006-01-17	2008-06-19	Abbott Laboratories	Combination therapy with parp inhibitors
EP2329818A1 (en) *	2006-01-17	2011-06-08	Abbott Laboratories	Combination therapy with PARP inhibitors
CA2647545C (en) *	2006-04-03	2016-02-23	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
MX2008014004A (es)	2006-05-02	2008-11-12	Abbott Lab	1h-benzimidazol-4-carboxamidas sustituidas son inhibidores de parp potentes.
US20080262062A1 (en) *	2006-11-20	2008-10-23	Bipar Sciences, Inc.	Method of treating diseases with parp inhibitors
CN101534836B (zh)	2006-09-05	2011-09-28	彼帕科学公司	Parp抑制剂在制备治疗肥胖症的药物中的用途
WO2008030883A2 (en)	2006-09-05	2008-03-13	Bipar Sciences, Inc.	Treatment of cancer
CA2662335A1 (en) *	2006-09-05	2008-03-13	Valeria Ossovskaya	Methods for designing parp inhibitors and uses thereof
GEP20115337B (en)	2007-01-10	2011-11-25	St Di Ricerche Di Biologia Molecolare P Angeletti Spa	Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
US8067613B2 (en)	2007-07-16	2011-11-29	Abbott Laboratories	Benzimidazole poly(ADP ribose)polymerase inhibitors
US20090062268A1 (en) *	2007-08-27	2009-03-05	Lead Therapeutics, Inc.	Novel inhibitors of poly(adp-ribose)polymerase (parp)
CN101903025A (zh) *	2007-10-19	2010-12-01	彼帕科学公司	利用苯并吡喃酮-型parp抑制剂治疗癌症的方法和组合物
CN103169973A (zh)	2007-11-12	2013-06-26	彼帕科学公司	使用4-碘-3-硝基苯甲酰胺化合物与抗肿瘤剂组合治疗乳腺癌
CN101932572A (zh)	2008-01-08	2010-12-29	默沙东有限公司	2-{4-[(3s)-哌啶-3-基]苯基}-2h-吲唑-7-羧酰胺的药学可接受的盐
MX2010008572A (es) *	2008-02-04	2010-11-30	Bipar Sciences Inc	Metodos de diagnostico y tratamiento de enfermedades mediadas por poli(adp-ribosa) polimerasa.
WO2010083199A1 (en)	2009-01-19	2010-07-22	Abbott Laboratories	Benzthiazole inhibitors of poly(adp-ribose)polymerase
JP2013521255A (ja) *	2010-03-04	2013-06-10	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	フルオロアルキル置換２−アミドベンズイミダゾールおよび植物中のストレス耐性を強化するためのその使用
CN102417483A (zh) *	2010-09-27	2012-04-18	中国药科大学	作为parp抑制剂的2-苯基-1h-苯并咪唑-4-甲酸酯衍生物
EP2561759A1 (en)	2011-08-26	2013-02-27	Bayer Cropscience AG	Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
CN103130723B (zh) *	2011-11-30	2015-01-14	成都地奥制药集团有限公司	一种多聚(adp-核糖)聚合酶抑制剂
CN102627610B (zh) *	2012-04-11	2014-06-25	江苏先声药物研究有限公司	一类苯并咪唑类衍生物及其应用
BR112015004858A2 (pt) *	2012-09-05	2017-07-04	Bayer Cropscience Ag	uso de 2-amidobenzimidazóis, 2-amidobenzoxazóis e 2-amidobenzotiazóis substituídos ou sais dos mesmos como substâncias ativas contra estresse abiótico em plantas
CN104140426B (zh) *	2013-05-07	2017-02-01	上海汇伦生命科技有限公司	嘧啶并咪唑类化合物、其药物组合物及其制备方法和用途
CN104230896A (zh) *	2013-06-17	2014-12-24	上海汇伦生命科技有限公司	苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途
CN107556288A (zh) *	2016-07-01	2018-01-09	山东大学齐鲁医院	一种治疗转移性肿瘤的药物化合物
US10874641B2 (en)	2016-07-28	2020-12-29	Mitobridge, Inc.	Methods of treating acute kidney injury
EP3534957A1 (en)	2016-11-02	2019-09-11	Immunogen, Inc.	Combination treatment with antibody-drug conjugates and parp inhibitors
WO2019136298A1 (en)	2018-01-05	2019-07-11	Cybrexa, Inc.	Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
WO2019195658A1 (en)	2018-04-05	2019-10-10	Dana-Farber Cancer Institute, Inc.	Sting levels as a biomarker for cancer immunotherapy
CN114302744A (zh)	2019-07-10	2022-04-08	赛博克萨3公司	作为治疗剂的微管靶向剂的肽缀合物
PE20220563A1 (es)	2019-07-10	2022-04-13	Cybrexa 2 Inc	Conjugados peptidicos de citotoxinas como terapeuticos
WO2021041532A1 (en)	2019-08-26	2021-03-04	Dana-Farber Cancer Institute, Inc.	Use of heparin to promote type 1 interferon signaling
CN111793034B (zh) *	2020-07-24	2021-11-19	华中科技大学	苯并咪唑盐衍生物与制备抗肿瘤药物的应用
EP4274905A1 (en)	2021-01-08	2023-11-15	Cybrexa 2, Inc.	Process for preparing a conjugate linking moiety
WO2022155172A1 (en)	2021-01-13	2022-07-21	Cybrexa 3, Inc.	Peptide conjugates of therapeutics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1087561A (en) *	1963-02-16	1967-10-18	Fisons Pest Control Ltd	Fluorinated benzimidazoles and compositions containing them
DE3346575A1 (de) *	1983-12-23	1985-07-04	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3522230A1 (de) *	1985-06-21	1987-01-02	Thomae Gmbh Dr K	Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8822483D0 (en) *	1988-09-24	1988-10-26	Medical Res Council	Developments relating to mas oncogene
GB8904174D0 (en) *	1989-02-23	1989-04-05	British Bio Technology	Compounds
IE70593B1 (en) *	1989-09-29	1996-12-11	Eisai Co Ltd	Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL95975A (en) *	1989-10-24	1997-06-10	Takeda Chemical Industries Ltd	N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
JP3208139B2 (ja) *	1990-10-02	2001-09-10	ワーナー−ランバート・コンパニー	アンギオテンシン▲ｉｉ▼アンタゴニスト
US5216003A (en) *	1992-01-02	1993-06-01	G. D. Searle & Co.	Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
AU675484B2 (en) *	1993-03-24	1997-02-06	Neurosearch A/S	Benzimidazole compounds, their use and preparation
US5824696A (en) *	1993-09-01	1998-10-20	Smithkline Beecham Corporation	Medicaments
US5735973A (en) *	1993-12-20	1998-04-07	Tamura Kaken Corporation	Printed circuit board surface protective agent
US5821258A (en) *	1994-12-27	1998-10-13	Mitsui Chemicals, Inc.	Phenylbenzimidazole derivatives

1996
- 1996-07-30 PT PT96925875T patent/PT841924E/pt unknown
- 1996-07-30 NZ NZ313713A patent/NZ313713A/en unknown
- 1996-07-30 WO PCT/GB1996/001832 patent/WO1997004771A1/en not_active Application Discontinuation
- 1996-07-30 AT AT96925875T patent/ATE225173T1/de not_active IP Right Cessation
- 1996-07-30 AP APAP/P/1998/001183A patent/AP866A/en active
- 1996-07-30 IL IL12314796A patent/IL123147A/en not_active IP Right Cessation
- 1996-07-30 CZ CZ98303A patent/CZ30398A3/cs unknown
- 1996-07-30 PL PL96324869A patent/PL324869A1/xx unknown
- 1996-07-30 BR BR9610051-6A patent/BR9610051A/pt not_active Application Discontinuation
- 1996-07-30 HU HU9901092A patent/HUP9901092A3/hu not_active Application Discontinuation
- 1996-07-30 ES ES96925875T patent/ES2183004T3/es not_active Expired - Lifetime
- 1996-07-30 CA CA002225465A patent/CA2225465A1/en not_active Abandoned
- 1996-07-30 AU AU66240/96A patent/AU714873B2/en not_active Ceased
- 1996-07-30 TR TR1998/00127T patent/TR199800127T1/xx unknown
- 1996-07-30 KR KR10-1998-0700752A patent/KR100447539B1/ko not_active IP Right Cessation
- 1996-07-30 DK DK96925875T patent/DK0841924T3/da active
- 1996-07-30 DE DE69624115T patent/DE69624115T2/de not_active Expired - Fee Related
- 1996-07-30 EP EP96925875A patent/EP0841924B1/en not_active Expired - Lifetime
- 1996-07-30 SK SK135-98A patent/SK13598A3/sk unknown
- 1996-07-30 EA EA199800184A patent/EA000999B1/ru not_active IP Right Cessation
- 1996-07-30 JP JP9507360A patent/JPH11510154A/ja not_active Ceased
- 1996-07-31 CN CNB961968818A patent/CN1159007C/zh not_active Expired - Fee Related
1998
- 1998-01-30 OA OA9800017A patent/OA10661A/en unknown
- 1998-01-30 NO NO19980414A patent/NO317033B1/no not_active IP Right Cessation
- 1998-02-02 US US09/017,314 patent/US6100283A/en not_active Expired - Fee Related
- 1998-02-02 MX MX9800927A patent/MX9800927A/es not_active IP Right Cessation
2000
- 2000-06-16 US US09/594,776 patent/US6310082B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
OA10661A (en)	2002-11-25
NO980414D0 (no)	1998-01-30
PL324869A1 (en)	1998-06-22
TR199800127T1 (xx)	1998-04-21
CN1195985A (zh)	1998-10-14
NZ313713A (en)	2001-03-30
EA199800184A1 (ru)	1998-10-29
DE69624115T2 (de)	2003-06-18
IL123147A (en)	2004-02-19
DK0841924T3 (da)	2003-02-10
JPH11510154A (ja)	1999-09-07
SK13598A3 (en)	1998-06-03
AP9801183A0 (en)	1998-01-31
AP866A (en)	2000-08-17
CN1159007C (zh)	2004-07-28
US6310082B1 (en)	2001-10-30
CA2225465A1 (en)	1997-02-13
HUP9901092A3 (en)	2001-11-28
AU6624096A (en)	1997-02-26
WO1997004771A1 (en)	1997-02-13
KR100447539B1 (ko)	2004-11-10
DE69624115D1 (de)	2002-11-07
KR19990036086A (ko)	1999-05-25
AU714873B2 (en)	2000-01-13
EP0841924A1 (en)	1998-05-20
ATE225173T1 (de)	2002-10-15
EP0841924B1 (en)	2002-10-02
HUP9901092A2 (hu)	1999-07-28
MX9800927A (es)	1998-10-31
EA000999B1 (ru)	2000-08-28
CZ30398A3 (cs)	1998-06-17
NO317033B1 (no)	2004-07-26
ES2183004T3 (es)	2003-03-16
BR9610051A (pt)	1999-12-21
US6100283A (en)	2000-08-08
NO980414L (no)	1998-04-02
IL123147A0 (en)	1998-09-24

Publication	Publication Date	Title
PT841924E (pt)	2003-02-28	Compostos de benzimidazolo
ID16345A (id)	1997-09-25	Senyawa-senyawa heterosiklik
BR9609989A (pt)	1999-07-06	Compostos de benzilaminopiperidina substituídos
FI972970A (fi)	1997-09-11	Uusia yhdisteitä
BR9612465A (pt)	1999-07-13	Compostos heterocíclicos
FI960519A0 (fi)	1996-02-05	Uusia yhdisteitä
BR9609682A (pt)	1999-07-06	Foto-desinfetantes de baixa nuança
DE59609887D1 (de)	2003-01-02	Substituierte cyanophenyluracile
DE69609678T2 (de)	2000-12-07	Synchronisiervorrichtung-Kupplung-Anordnung
DE69622196T2 (de)	2002-10-31	Motorträgeranordnung
BR9600251A (pt)	1997-12-23	Composto
IS4739A (is)	1998-05-12	Efnasambönd
NO974170D0 (no)	1997-09-09	Polyazacykloalkan-forbindelser
DE59610332D1 (de)	2003-05-15	Substituierte aminouracile
BR9601295A (pt)	1998-01-13	Composto
DK0760210T3 (da)	2002-04-15	Nultids-klemmeindretning
BR9608890A (pt)	1999-06-15	N-metilenotiouréias substituídas
BR9609319A (pt)	1999-07-06	Carbonilaminofeniluracilas substituídas
BR9611576A (pt)	1999-03-30	Composto
BR9603376A (pt)	1998-05-12	Tetrahidro-5-nitro-pirimidinas substituídas
PT839024E (pt)	2004-08-31	Formulacoes de monensina
DE59607732D1 (de)	2001-10-25	Substituierte benzylidencyanessigester
ID18956A (id)	1998-05-28	Senyawa-senyawa herbisida
DE59607958D1 (de)	2001-11-22	Substituierte phenyluracile
DE69622816T2 (de)	2002-11-28	Polyolefinfolie